Panel rejects child images on syrups

Benchmarks
Nifty22,776.10220.35
FEATURED FUNDS★★★★★
Motilal Oswal Midcap Fund Direct-Growth
5Y Return
19.73 %
Invest Now
Enter search text:
Business News›Industry›Healthcare/Biotech›Healthcare›Drug panel rejects child images on cough syrup labels, proposes age warning for use below 4 years
Read Today's Paper
Drug panel rejects child images on cough syrup labels, proposes age warning for use below 4 years
Synopsis
Cough syrup bottles will soon include a prominent red warning stating their use is not recommended for children under four. An expert committee rejected child-oriented imagery on labels, which could imply suitability for young children. This decision follows ongoing concerns about the safety of cough syrups in pediatric care. The proposed change aims to prevent confusion regarding age restrictions for these medications.
ET BureauPanel rejects child images on syrups
New Delhi: An expert committee has rejected a proposal to allow pictures of infants, toddlers, toys or similar child-oriented imagery on cough syrup labels, saying such depictions could suggest that the medicines are meant for use in young children. Instead, it proposed to carry a prominent warning in red on cough syrup bottles, stating that they should not be used in children below four years of age, according to documents seen by ET.
The government is considering the recommendation and may soon amend the drugs rules to give effect to the labelling requirement proposed by the drugs consultative committee.
Also read: Cough syrup bottles may soon carry a warning label in 'red'
The DCC recently deliberated on the proposal that came from within the committee. It agreed in principle to introduce the statutory warning on age restriction under Rule 96 of the Drugs Rules, 1945, amid continued concerns over the prescription of cough syrups to infants and young children.
The warning proposed by the committee will read: "WARNING: Cough syrup shall not be used in children below 4 years of age." The warning must be displayed prominently in red and in an appropriately large font size on the label, it said.
The original proposal was that a pictorial depiction of school-age children could be included on the bottle labels to reinforce that the product was intended for older children and discourage its use below the specified age. The committee said such depictions could create confusion and proposed inclusion of the red warning instead. ET reported about the proposal in September.
The move comes amid continued concerns over the use of cough and cold medicines in paediatric care. A directorate general of health services (DGHS) advisory issued in October 2025 called for judicious prescription and dispensation of such medicines. It specifically advised against prescribing those drugs for children below two years of age.
(You can now subscribe to our WhatsApp channel)
(Catch all the Business News, Breaking News and Latest News Updates on The .)
…moreless
(You can now subscribe to our WhatsApp channel)
Read More News on
cough syrup labelscough syrup age restrictionschildren medication warningssyrup use in infantsexpert committee recommendationspaediatric cough medicinepediatric care advisoryIndian Council of Medical ResearchDrugs Rules 1945regulatory changes in drug labels
(Catch all the Business News, Breaking News and Latest News Updates on The .)
…moreless


Enter search text:
Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories
& personalised newsletters
Login Now
Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions &
in-depth stock reports
Subscribe Now
ET
Unlock Access to All Exclusives with ETPrime FREE TRIAL
15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers
Trial offer expiring in00 : 05 : 00
I'd rather pay ₹2599 now


Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Prime Account Detected!
It seems like you're already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.
Unlock ETPrime's Exclusive Stories Today!
Subscribe to gain powerful insights on business, stock market and industry trends.
Big Price Drop! Flat 40% Off
Student Only Offer
Already a Member? Sign In now
Already a Member? Sign In now
Already a Member? Sign In now
Offer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail Offer
Offer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail Offer
Special Offer
Get flat 40% off on ETPrime
Avail Offer
Avail Offer
Claim NowAlready a Member? Sign In now
Need Assistance?
Connect with an ETPrime expert for personalized support and guidance
+91 9484700004
' + h3 + '
' + h4 + '
- ' + listing + '
What’s Included with
ETPrime Membership
1Exclusive Insights That Matter
Uncover the truth with our investigative stories
Make strategic moves using the real-world case studies
Read industry-specific stories to identify emerging trends
Spot opportunities with in-depth insights that matter
Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

The problem with lab grown diamonds
Why a falling rupee is a better option for the economy

A list of top 20 momentum stocks that have delivered massive returns in one year
2Invest Wisely With Smart Market Tools & Investment Ideas
Alpha Trade
Get daily trade ideas from SEBI-registered research analysts.
Investment Ideas
Grow your wealth with stock ideas & sectoral trends.
Stock Reports Plus
All-in-one stock research with Stock Score, peer comparison & key signals.
BigBull Portfolio
Get to know where the market bulls are investing to identify the right stocks.
Stock Analyzer
Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.
Market Mood
Analyze the market sentiments & identify the trend reversal for strategic decisions.
Stock Talk Live at 9 AM Daily
Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.
3Stay informed anytime, anywhere with ET ePaper
ePaper – Print View
Read the PDF version of ET newspaper. Download & access it offline anytime.
ePaper – Digital View
Read your daily newspaper in Digital View & get it delivered to your inbox everyday.
Wealth Edition
Manage your money efficiently with this weekly money management guide.
4Times Of India Subscription (1 Year)
ePaper
Read the PDF version of newspaper. Download & access it offline anytime.
Deep Explainers
Explore the In-depth explanation of complex topics for everyday life decisions.
Health+ Stories
Get fitter with daily health insights committed to your well-being.
Personal Finance+ Stories
Manage your wealth better with in-depth insights & updates on finance.
5Enjoy Complimentary Subscriptions From Top Brands
Docubay Subscription
Stream new documentaries from all across the world every day.
Stories you might be interested in




Leave a Reply